LB2 - Safety and Efficacy of Combination SARS-CoV-2 Monoclonal Neutralizing Antibodies (mAb) BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients

Presenting Author(s)

• TE

  Teresa H. Evering, MD

  Assistant Professor of Medicine
  Weill Cornell Medicine
  New York, NY, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.

Co-Author(s)

• MG

  Mark Giganti, Ph.D.

  Harvard T.H. Chan School of Public Health
  Boston, Massachusetts, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Kara W. Chew, MD, MS

  Associate Professor
  David Geffen School of Medicine at UCLA

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MH

  Michael Hughes, Ph.D.

  Harvard T.H. Chan School of Public Health
  Boston, Massachusetts, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CM

  Carlee Moser, Ph.D.

  Harvard T.H. Chan School of Public Health
  Boston, Massachusetts, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  David Alain Wohl, MD

  Professor of Medicine
  UNC School of Medicine
  Chapel Hill, NC, United States

  Gilead Sciences (Individual(s) Involved: Self): Advisor or Review Panel member, Consultant, Research Grant or Support, Scientific Research Study Investigator; Janssen (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member, Research Grant or Support; ViiV (Individual(s) Involved: Self): Advisor or Review Panel member, Research Grant or Support
• JC

  Judith Currier, M.D., M.Sc.

  David Geffen School of Medicine at University of California, Los Angeles
  Los Angeles, California, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Joseph J. Eron, MD

  Professor
  University of North Carolina at Chapel Hill
  Chapel Hill, North Carolina, United States

  Gilead Sciences (Consultant, Research Grant or Support)Janssen (Consultant, Research Grant or Support)Merck (Consultant)ViiV (Consultant, Research Grant or Support)
• AJ

  Arzhang Javan, M.D., M.P.H., D.T.M&H

  National Institute of Health
  Bethesda, Maryland, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  David A. Margolis, MD MPH

  Head of Infectious Diseases Therapy Area
  Brii Biosciences
  Chapel Hill, North Carolina, United States

  Brii Biosciences (Employee)
• QZ

  Qing Zhu, PhD

  Brii Biosciences
  durham, North Carolina, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• UD

  Ulises D'Andrea, MD

  Sub-investigator
  Instituto Medico Rio Cuarto
  Rio Cuarto, Cordoba, Argentina

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KH

  Keila Hoover, M.D.

  PI
  Miami Clinical Research
  Miami, Florida, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• BM

  Bharat R. Mocherla, M.D.

  Medical Director
  Las Vegas Medical Research
  Las Vegas, Nevada, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CF

  Courtney Fletcher, Pharm.D.

  University of Nebraska
  Omaha, Nebraska, United States

  National Institute of Allergy and Infectious Diseases , NIH (Grant/Research Support)
• JL

  Jonathan Li, M.D., M.M.Sc.

  Brigham & Womens Hospital
  Boston, Massachusetts, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DS

  Davey Smith, M.D.

  University of California, San Diego
  San Diego, California, United States

  Linear Therapies, Matrix Biomed, Bayer (Consultant, Shareholder)
• ED

  Eric Daar

  Gilead (Consultant, Grant/Research Support)Merck (Consultant)ViiV (Consultant, Grant/Research Support)